1] Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Station Centre-ville, Montréal, Québec, Canada H3C 3J7 [2] Department of Chemistry, Université de Montréal, PO Box 6128, Station Centre-ville, Montréal, Québec, Canada H3C 3J7.
Institute for Research in Immunology and Cancer, Université de Montréal, PO Box 6128, Station Centre-ville, Montréal, Québec, Canada H3C 3J7.
Nat Commun. 2014 Nov 13;5:5409. doi: 10.1038/ncomms6409.
Small ubiquitin-related modifiers (SUMO) are evolutionarily conserved ubiquitin-like proteins that regulate several cellular processes including cell cycle progression, intracellular trafficking, protein degradation and apoptosis. Despite the importance of protein SUMOylation in different biological pathways, the global identification of acceptor sites in complex cell extracts remains a challenge. Here we generate a monoclonal antibody that enriches for peptides containing SUMO remnant chains following tryptic digestion. We identify 954 SUMO3-modified lysine residues on 538 proteins and profile by quantitative proteomics the dynamic changes of protein SUMOylation following proteasome inhibition. More than 86% of these SUMOylation sites have not been reported previously, including 5 sites on the tumour suppressor parafibromin (CDC73). The modification of CDC73 at K136 affects its nuclear retention within PML nuclear bodies on proteasome inhibition. In contrast, a CDC73 K136R mutant translocates to the cytoplasm under the same conditions, further demonstrating the effectiveness of our method to characterize the dynamics of lysine SUMOylation.
小泛素相关修饰物(SUMO)是进化上保守的泛素样蛋白,调节包括细胞周期进程、细胞内运输、蛋白质降解和细胞凋亡在内的多种细胞过程。尽管蛋白质 SUMO 化在不同的生物途径中很重要,但在复杂的细胞提取物中对受体位点进行全局鉴定仍然是一个挑战。在这里,我们生成了一种单克隆抗体,该抗体可在胰蛋白酶消化后富集含有 SUMO 残留链的肽段。我们在 538 种蛋白质上鉴定了 954 个 SUMO3 修饰的赖氨酸残基,并通过定量蛋白质组学分析了蛋白酶体抑制后蛋白质 SUMO 化的动态变化。这些 SUMO 化位点中超过 86%以前没有报道过,包括肿瘤抑制因子 parafibromin(CDC73)上的 5 个位点。CDC73 在 K136 上的修饰会影响其在蛋白酶体抑制时在 PML 核体中的核内保留。相比之下,在相同条件下,CDC73 K136R 突变体易位到细胞质中,进一步证明了我们的方法在表征赖氨酸 SUMO 化动力学方面的有效性。